Selisistat is a potent and selective SIRT1 class III histone deacetylase enzyme inhibitor. It is selective inhibitor of SIRT1 that does not class I/II inhibit histone deacetylase (HDAC) or other sirtuin deacetylase family members. EX- 527 has been used a powerful tool for studying the relationship between SIRT1 and cell regulation.
This report contains market size and forecasts of Selisistat(EX-527) in global, including the following market information:
Global Selisistat(EX-527) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Selisistat(EX-527) Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Selisistat(EX-527) companies in 2021 (%)
The global Selisistat(EX-527) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Selisistat(EX-527) include Thermo Fisher Scientific, Abcam, Merck, Cayman Chemical, Santa Cruz Biotechnology, BioVision, Enzo Biochem, STEMCELL Technologies and Selleck Chemicals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Selisistat(EX-527) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Selisistat(EX-527) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Selisistat(EX-527) Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Selisistat(EX-527) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Selisistat(EX-527) Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Selisistat(EX-527) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Selisistat(EX-527) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Selisistat(EX-527) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Selisistat(EX-527) revenues share in global market, 2021 (%)
Key companies Selisistat(EX-527) sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Selisistat(EX-527) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Abcam
Merck
Cayman Chemical
Santa Cruz Biotechnology
BioVision
Enzo Biochem
STEMCELL Technologies
Selleck Chemicals
Bio-Techne
PeproTech
Arbor Assays
APExBIO Technology
BioCrick
Adooq Bioscience
BioVision
BPS Bioscience
Abmole Bioscience
Active Motif
Beyotime
Focus Biomolecules